Logo image of RIGL

RIGEL PHARMACEUTICALS INC (RIGL) Stock Fundamental Analysis

USA - NASDAQ:RIGL - US7665597024 - Common Stock

28.085 USD
-0.02 (-0.09%)
Last: 10/17/2025, 12:37:54 PM
Fundamental Rating

6

RIGL gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 536 industry peers in the Biotechnology industry. Both the profitability and the financial health of RIGL get a neutral evaluation. Nothing too spectacular is happening here. RIGL has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! With these ratings, RIGL could be worth investigating further for value and growth investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year RIGL was profitable.
In the past year RIGL had a positive cash flow from operations.
In the past 5 years RIGL reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: RIGL reported negative operating cash flow in multiple years.
RIGL Yearly Net Income VS EBIT VS OCF VS FCFRIGL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

RIGL has a Return On Assets of 47.32%. This is amongst the best in the industry. RIGL outperforms 99.63% of its industry peers.
Looking at the Return On Equity, with a value of 119.39%, RIGL belongs to the top of the industry, outperforming 99.25% of the companies in the same industry.
With an excellent Return On Invested Capital value of 68.80%, RIGL belongs to the best of the industry, outperforming 99.81% of the companies in the same industry.
Industry RankSector Rank
ROA 47.32%
ROE 119.39%
ROIC 68.8%
ROA(3y)-18.12%
ROA(5y)-18.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RIGL Yearly ROA, ROE, ROICRIGL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400

1.3 Margins

The Profit Margin of RIGL (36.51%) is better than 97.01% of its industry peers.
With an excellent Operating Margin value of 39.04%, RIGL belongs to the best of the industry, outperforming 98.51% of the companies in the same industry.
The Gross Margin of RIGL (91.52%) is better than 92.16% of its industry peers.
RIGL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 39.04%
PM (TTM) 36.51%
GM 91.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5Y-1.87%
RIGL Yearly Profit, Operating, Gross MarginsRIGL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so RIGL is creating value.
The number of shares outstanding for RIGL has been increased compared to 1 year ago.
Compared to 5 years ago, RIGL has less shares outstanding
Compared to 1 year ago, RIGL has an improved debt to assets ratio.
RIGL Yearly Shares OutstandingRIGL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
RIGL Yearly Total Debt VS Total AssetsRIGL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

RIGL has an Altman-Z score of -3.03. This is a bad value and indicates that RIGL is not financially healthy and even has some risk of bankruptcy.
RIGL's Altman-Z score of -3.03 is in line compared to the rest of the industry. RIGL outperforms 46.46% of its industry peers.
RIGL has a debt to FCF ratio of 0.91. This is a very positive value and a sign of high solvency as it would only need 0.91 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.91, RIGL belongs to the top of the industry, outperforming 94.78% of the companies in the same industry.
RIGL has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
RIGL has a Debt to Equity ratio of 0.46. This is in the lower half of the industry: RIGL underperforms 71.83% of its industry peers.
Even though the debt/equity ratio score it not favorable for RIGL, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 0.91
Altman-Z -3.03
ROIC/WACC7
WACC9.83%
RIGL Yearly LT Debt VS Equity VS FCFRIGL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

A Current Ratio of 2.02 indicates that RIGL has no problem at all paying its short term obligations.
With a Current ratio value of 2.02, RIGL is not doing good in the industry: 74.44% of the companies in the same industry are doing better.
A Quick Ratio of 1.90 indicates that RIGL should not have too much problems paying its short term obligations.
The Quick ratio of RIGL (1.90) is worse than 74.81% of its industry peers.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 1.9
RIGL Yearly Current Assets VS Current LiabilitesRIGL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 729.07% over the past year.
The Revenue has grown by 105.62% in the past year. This is a very strong growth!
The Revenue has been growing by 24.77% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)729.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5566.67%
Revenue 1Y (TTM)105.62%
Revenue growth 3Y6.31%
Revenue growth 5Y24.77%
Sales Q2Q%176.01%

3.2 Future

The Earnings Per Share is expected to grow by 29.86% on average over the next years. This is a very strong growth
RIGL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.40% yearly.
EPS Next Y503.1%
EPS Next 2Y102.44%
EPS Next 3Y61.96%
EPS Next 5Y29.86%
Revenue Next Year62.09%
Revenue Next 2Y26.39%
Revenue Next 3Y18.97%
Revenue Next 5Y14.4%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
RIGL Yearly Revenue VS EstimatesRIGL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M
RIGL Yearly EPS VS EstimatesRIGL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 5 -5 -10

More info and screens

10

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 5.19 indicates a rather cheap valuation of RIGL.
98.51% of the companies in the same industry are more expensive than RIGL, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of RIGL to the average of the S&P500 Index (27.29), we can say RIGL is valued rather cheaply.
RIGL is valuated cheaply with a Price/Forward Earnings ratio of 7.29.
Compared to the rest of the industry, the Price/Forward Earnings ratio of RIGL indicates a rather cheap valuation: RIGL is cheaper than 98.51% of the companies listed in the same industry.
RIGL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.85.
Industry RankSector Rank
PE 5.19
Fwd PE 7.29
RIGL Price Earnings VS Forward Price EarningsRIGL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

98.88% of the companies in the same industry are more expensive than RIGL, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, RIGL is valued cheaply inside the industry as 98.69% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.66
EV/EBITDA 3.74
RIGL Per share dataRIGL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

RIGL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of RIGL may justify a higher PE ratio.
RIGL's earnings are expected to grow with 61.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y102.44%
EPS Next 3Y61.96%

More info and screens

0

5. Dividend

5.1 Amount

RIGL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RIGEL PHARMACEUTICALS INC

NASDAQ:RIGL (10/17/2025, 12:37:54 PM)

28.085

-0.02 (-0.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners80.02%
Inst Owner Change-1.92%
Ins Owners2.58%
Ins Owner Change1.25%
Market Cap503.84M
Analysts76.67
Price Target39.1 (39.22%)
Short Float %12.6%
Short Ratio3.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)308.53%
Min EPS beat(2)24.64%
Max EPS beat(2)592.43%
EPS beat(4)4
Avg EPS beat(4)440.39%
Min EPS beat(4)24.64%
Max EPS beat(4)1076.54%
EPS beat(8)7
Avg EPS beat(8)241.24%
EPS beat(12)11
Avg EPS beat(12)177.31%
EPS beat(16)13
Avg EPS beat(16)133.23%
Revenue beat(2)2
Avg Revenue beat(2)15.63%
Min Revenue beat(2)12.08%
Max Revenue beat(2)19.17%
Revenue beat(4)4
Avg Revenue beat(4)17.43%
Min Revenue beat(4)9.15%
Max Revenue beat(4)29.32%
Revenue beat(8)7
Avg Revenue beat(8)9.33%
Revenue beat(12)10
Avg Revenue beat(12)13.36%
Revenue beat(16)11
Avg Revenue beat(16)9.9%
PT rev (1m)0%
PT rev (3m)13.61%
EPS NQ rev (1m)0%
EPS NQ rev (3m)307.02%
EPS NY rev (1m)0%
EPS NY rev (3m)380.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)22.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)39.78%
Valuation
Industry RankSector Rank
PE 5.19
Fwd PE 7.29
P/S 1.88
P/FCF 7.66
P/OCF 7.65
P/B 6.15
P/tB 9
EV/EBITDA 3.74
EPS(TTM)5.41
EY19.26%
EPS(NY)3.85
Fwd EY13.72%
FCF(TTM)3.67
FCFY13.06%
OCF(TTM)3.67
OCFY13.06%
SpS14.93
BVpS4.57
TBVpS3.12
PEG (NY)0.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 47.32%
ROE 119.39%
ROCE 87.08%
ROIC 68.8%
ROICexc 704.92%
ROICexgc N/A
OM 39.04%
PM (TTM) 36.51%
GM 91.52%
FCFM 24.56%
ROA(3y)-18.12%
ROA(5y)-18.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5Y-1.87%
F-Score6
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 0.91
Debt/EBITDA 0.35
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 15.13
Cash Conversion 61.51%
Profit Quality 67.26%
Current Ratio 2.02
Quick Ratio 1.9
Altman-Z -3.03
F-Score6
WACC9.83%
ROIC/WACC7
Cap/Depr(3y)424.8%
Cap/Depr(5y)301.24%
Cap/Sales(3y)4.48%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)729.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5566.67%
EPS Next Y503.1%
EPS Next 2Y102.44%
EPS Next 3Y61.96%
EPS Next 5Y29.86%
Revenue 1Y (TTM)105.62%
Revenue growth 3Y6.31%
Revenue growth 5Y24.77%
Sales Q2Q%176.01%
Revenue Next Year62.09%
Revenue Next 2Y26.39%
Revenue Next 3Y18.97%
Revenue Next 5Y14.4%
EBIT growth 1Y1259.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year470.56%
EBIT Next 3Y88.04%
EBIT Next 5YN/A
FCF growth 1Y235.34%
FCF growth 3Y80.89%
FCF growth 5YN/A
OCF growth 1Y297.38%
OCF growth 3Y74.92%
OCF growth 5YN/A